The .NET library (formerly called .NET Core) doesn't have built-in functions for classical statistics analyses. But it is possible to implement such functions from scratch. This article presents C# ...

A large new study found that beta blockers did not provide clear benefits for heart attack patients whose hearts were still ...

A new major trial shows that beta-blockers don't provide any real benefit to people with the most common form of heart attack ...

Standard drugs given after a heart attack may not benefit those with preserved heart function — and may lead to more risk in ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical ...

Results from this trial of more than 5,000 adults diagnosed with a heart attack and either mildly decreased or intact heart ...

To investigate whether dedifferentiated beta cells can be targeted pharmacologically to restore beta cell function, the researchers used streptozotocin-induced diabetes in mice.

To investigate whether dedifferentiated beta cells can be targeted pharmacologically to restore beta cell function, the researchers used streptozotocin-induced diabetes in mice.

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine. ...

Two new trials and a meta-analysis presented at the European Society of Cardiology Congress put the spotlight on the use of beta-blocker therapy after myocardial infarction in patients with preserved ...

Greater weight loss and improved beta-cell function are tied to long-term glycemic control with tirzepatide.